FDA moves to fast-track psychedelic drug reviews
Digest more
DemeRx, Inc., a clinical-stage biopharmaceutical company dedicated to transforming addiction therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has accepted its ...
Farhadullah found himself on a path he never expected from a young age. While other kids his age were still in school, ...
Prescription weight loss medications have become more popular in recent years, including medications like Ozempic and Wegovy. Medications that were created to treat diabetes or obesity are now being ...
In 2003, Wendy Dossett chaired an international symposium at a UK university. “I don’t remember chairing it. I know that I did, but I don’t remember anything that happened,” she says. At the time, she ...
Mental health and substance abuse disorders are the leading cause of disease burden — both financially and in terms of utilization — in the U.S., according to Kaiser Family Foundation. And compared ...
Hosted on MSN
5 surprising opioid use disorder statistics
Opioid use disorder (OUD) is a serious and complex condition affecting millions of people across the country and contributing to a national public health emergency. Yet stigma and misinformation ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A staggering 19 million U.S. children were estimated to be living in a ...
Adial Pharmaceuticals Inc. ADIL said Wednesday it has completed demonstration batch production for its lead candidate AD04, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results